Compile Data Set for Download or QSAR
Report error Found 47 Enz. Inhib. hit(s) with all data for entry = 50032338
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327343(2-(4-(8-fluoroquinoxalin-6-yl)-3-methyl-1-o-tolyl-...)
Affinity DataIC50: 0.600nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327327(2-(4-(4-fluorophenyl)-3-methyl-1-o-tolyl-1H-pyrazo...)
Affinity DataIC50: 1.39nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327337(5-methoxy-2-(3-methyl-1-phenyl-4-(quinoxalin-6-yl)...)
Affinity DataIC50: 2.80nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327325(5-methoxy-2-(3-methyl-1-o-tolyl-4-p-tolyl-1H-pyraz...)
Affinity DataIC50: 3.16nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327333(5-methoxy-2-(3-methyl-4-(quinoxalin-6-yl)-1-o-toly...)
Affinity DataIC50: 3.20nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327335(5-methyl-2-(3-methyl-4-(quinoxalin-6-yl)-1-o-tolyl...)
Affinity DataIC50: 5.10nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327339(2-(1-(2-ethylphenyl)-3-methyl-4-(quinoxalin-6-yl)-...)
Affinity DataIC50: 6.40nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327323(2-(1-(2-chlorophenyl)-3-methyl-4-(quinoxalin-6-yl)...)
Affinity DataIC50: 7.30nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327336(2-(3-methyl-4-(quinoxalin-6-yl)-1-o-tolyl-1H-pyraz...)
Affinity DataIC50: 8nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327340(2-(4-(quinoxalin-6-yl)-1-o-tolyl-3-(trifluoromethy...)
Affinity DataIC50: 9nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327341(2-(3-ethyl-4-(quinoxalin-6-yl)-1-o-tolyl-1H-pyrazo...)
Affinity DataIC50: 13nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327334(5-chloro-2-(3-methyl-4-(quinoxalin-6-yl)-1-o-tolyl...)
Affinity DataIC50: 16nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327332(2-(4-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-methy...)
Affinity DataIC50: 27nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327324(2-(4-(4-acetylphenyl)-3-methyl-1-o-tolyl-1H-pyrazo...)
Affinity DataIC50: 40nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327331(2-(4-(benzo[d][1,3]dioxol-5-yl)-3-methyl-1-o-tolyl...)
Affinity DataIC50: 231nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327330(2-(4-(3,4-dimethoxyphenyl)-3-methyl-1-o-tolyl-1H-p...)
Affinity DataIC50: 233nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327342(2-(4-(quinoxalin-6-yl)-1-o-tolyl-1H-pyrazol-5-ylam...)
Affinity DataIC50: 277nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327328(2-(4-(3,4-difluorophenyl)-3-methyl-1-o-tolyl-1H-py...)
Affinity DataIC50: 294nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327329(5-methoxy-2-(4-(4-methoxyphenyl)-3-methyl-1-o-toly...)
Affinity DataIC50: 306nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327338(2-(1-cyclohexyl-3-methyl-4-(quinoxalin-6-yl)-1H-py...)
Affinity DataIC50: 435nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A1(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327326(2-(4-(3,4-dimethylphenyl)-3-methyl-1-o-tolyl-1H-py...)
Affinity DataIC50: 568nMAssay Description:Antagonist activity at adenosine A1 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327337(5-methoxy-2-(3-methyl-1-phenyl-4-(quinoxalin-6-yl)...)
Affinity DataIC50: 1.10E+3nMAssay Description:Antagonist activity at adenosine A2B receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327337(5-methoxy-2-(3-methyl-1-phenyl-4-(quinoxalin-6-yl)...)
Affinity DataIC50: 5.50E+3nMAssay Description:Antagonist activity at adenosine A2A receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A3(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327343(2-(4-(8-fluoroquinoxalin-6-yl)-3-methyl-1-o-tolyl-...)
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at adenosine A3 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A3(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327333(5-methoxy-2-(3-methyl-4-(quinoxalin-6-yl)-1-o-toly...)
Affinity DataIC50: 1.30E+4nMAssay Description:Antagonist activity at adenosine A3 receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327340(2-(4-(quinoxalin-6-yl)-1-o-tolyl-3-(trifluoromethy...)
Affinity DataIC50: 1.90E+4nMAssay Description:Antagonist activity at adenosine A2B receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327335(5-methyl-2-(3-methyl-4-(quinoxalin-6-yl)-1-o-tolyl...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2B receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327323(2-(1-(2-chlorophenyl)-3-methyl-4-(quinoxalin-6-yl)...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2A receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327343(2-(4-(8-fluoroquinoxalin-6-yl)-3-methyl-1-o-tolyl-...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2B receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327342(2-(4-(quinoxalin-6-yl)-1-o-tolyl-1H-pyrazol-5-ylam...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2B receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327341(2-(3-ethyl-4-(quinoxalin-6-yl)-1-o-tolyl-1H-pyrazo...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2B receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327339(2-(1-(2-ethylphenyl)-3-methyl-4-(quinoxalin-6-yl)-...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2B receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327323(2-(1-(2-chlorophenyl)-3-methyl-4-(quinoxalin-6-yl)...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2B receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327338(2-(1-cyclohexyl-3-methyl-4-(quinoxalin-6-yl)-1H-py...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2B receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327333(5-methoxy-2-(3-methyl-4-(quinoxalin-6-yl)-1-o-toly...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2A receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327336(2-(3-methyl-4-(quinoxalin-6-yl)-1-o-tolyl-1H-pyraz...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2B receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327335(5-methyl-2-(3-methyl-4-(quinoxalin-6-yl)-1-o-tolyl...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2A receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327334(5-chloro-2-(3-methyl-4-(quinoxalin-6-yl)-1-o-tolyl...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2B receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327333(5-methoxy-2-(3-methyl-4-(quinoxalin-6-yl)-1-o-toly...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2B receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327343(2-(4-(8-fluoroquinoxalin-6-yl)-3-methyl-1-o-tolyl-...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2A receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327342(2-(4-(quinoxalin-6-yl)-1-o-tolyl-1H-pyrazol-5-ylam...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2A receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327341(2-(3-ethyl-4-(quinoxalin-6-yl)-1-o-tolyl-1H-pyrazo...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2A receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327340(2-(4-(quinoxalin-6-yl)-1-o-tolyl-3-(trifluoromethy...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2A receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327339(2-(1-(2-ethylphenyl)-3-methyl-4-(quinoxalin-6-yl)-...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2A receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327338(2-(1-cyclohexyl-3-methyl-4-(quinoxalin-6-yl)-1H-py...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2A receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327334(5-chloro-2-(3-methyl-4-(quinoxalin-6-yl)-1-o-tolyl...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2A receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Bayer Schering Pharma

Curated by ChEMBL
LigandPNGBDBM50327336(2-(3-methyl-4-(quinoxalin-6-yl)-1-o-tolyl-1H-pyraz...)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at adenosine A2A receptor by cAMP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed